Rodent models of neuroinflammation for Alzheimer's disease
A Nazem, R Sankowski, M Bacher… - Journal of …, 2015 - Springer
Alzheimer's disease remains incurable, and the failures of current disease-modifying
strategies for Alzheimer's disease could be attributed to a lack of in vivo models that …
strategies for Alzheimer's disease could be attributed to a lack of in vivo models that …
Zebrafish as a model organism for neurodegenerative disease
K Chia, A Klingseisen, D Sieger… - Frontiers in molecular …, 2022 - frontiersin.org
The zebrafish is increasingly recognized as a model organism for translational research into
human neuropathology. The zebrafish brain exhibits fundamental resemblance with human …
human neuropathology. The zebrafish brain exhibits fundamental resemblance with human …
Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease
C Gao, X Chu, W Gong, J Zheng, X Xie, Y Wang… - Journal of …, 2020 - Springer
Background Although many therapeutic strategies for Alzheimer's disease (AD) have been
explored, these strategies are seldom used in the clinic. Therefore, AD therapeutic research …
explored, these strategies are seldom used in the clinic. Therefore, AD therapeutic research …
Customized Intranasal Hydrogel Delivering Methylene Blue Ameliorates Cognitive Dysfunction against Alzheimer's Disease
Y Liu, Y Tan, G Cheng, Y Ni, A Xie, X Zhu… - Advanced …, 2024 - Wiley Online Library
The accumulation of hyperphosphorylated tau protein aggregates is a key pathogenic event
in Alzheimer's disease (AD) and induces mitochondrial dysfunction and reactive oxygen …
in Alzheimer's disease (AD) and induces mitochondrial dysfunction and reactive oxygen …
[HTML][HTML] Marine-derived pharmaceuticals–challenges and opportunities
U Lindequist - Biomolecules & therapeutics, 2016 - ncbi.nlm.nih.gov
Marine biosphere is the largest one of the earth and harbors an enormous number of
different organisms. Living conditions differ fundamentally from those in terrestrial …
different organisms. Living conditions differ fundamentally from those in terrestrial …
The cellular model for Alzheimer's disease research: PC12 cells
D Xie, T Deng, Z Zhai, T Sun, Y Xu - Frontiers in Molecular …, 2023 - frontiersin.org
Alzheimer's disease (AD) is a common age-related neurodegenerative disease
characterized by progressive cognitive decline and irreversible memory impairment …
characterized by progressive cognitive decline and irreversible memory impairment …
Gold nanoparticles treatment reverses brain damage in Alzheimer's disease model
N dos Santos Tramontin, S da Silva, R Arruda… - Molecular …, 2020 - Springer
Alzheimer's disease (AD) is characterized by amyloid (A) β peptide accumulation and
intracellular neurofibrillary tangles. New hypotheses have suggested that AD involves …
intracellular neurofibrillary tangles. New hypotheses have suggested that AD involves …
Current trends and new challenges in marine phycotoxins
Marine phycotoxins are a multiplicity of bioactive compounds which are produced by
microalgae and bioaccumulate in the marine food web. Phycotoxins affect the ecosystem …
microalgae and bioaccumulate in the marine food web. Phycotoxins affect the ecosystem …
HGF mediates clinical‐grade human umbilical cord‐derived mesenchymal stem cells improved functional recovery in a senescence‐accelerated mouse model of …
Y Jia, N Cao, J Zhai, Q Zeng, P Zheng, R Su… - Advanced …, 2020 - Wiley Online Library
Stem cells have emerged as a potential therapy for a range of neural insults, but their
application in Alzheimer's disease (AD) is still limited and the mechanisms underlying the …
application in Alzheimer's disease (AD) is still limited and the mechanisms underlying the …
Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment
J Gasparotto, CS Girardi, N Somensi, CT Ribeiro… - Journal of Biological …, 2018 - ASBMB
Patients recovering from sepsis have higher rates of CNS morbidities associated with long-
lasting impairment of cognitive functions, including neurodegenerative diseases. However …
lasting impairment of cognitive functions, including neurodegenerative diseases. However …